<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02038062</url>
  </required_header>
  <id_info>
    <org_study_id>Fudickar7</org_study_id>
    <nct_id>NCT02038062</nct_id>
  </id_info>
  <brief_title>Tissue Oxygenation of the Tibial Anterior Muscle After Clamping of the Femoral Artery</brief_title>
  <acronym>NIRSFEM</acronym>
  <official_title>Influence of Sevoflurane Preconditioning on Tissue Oxygenation of the Tibial Anterior Muscle Measured by Near-infrared Spectroscopy After Clamping of the Femoral Artery for Vascular Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Schleswig-Holstein</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ischemic preconditioning is defined as protection from cell damage induced by prolonged
      ischemia by preceding cycles of short ischemia. Hence, ischemic preconditioning could reduce
      ischemic lesion during clamping a femoral artery for vascular surgery. In this prospective,
      randomized pilot study is investigated if clamping of the femoral artery leads to ischemia of
      the calf measurable by near-infrared spectroscopy. In addition to this, the effect of
      sevoflurane preconditioning on ischemia of the calf is measured.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ischemic preconditioning is performed by clamping of the femoral artery for five minutes in
      40 patients. In 20 patients sevoflurane preconditioning is performed five minutes before
      ischemic preconditioning by inducing sevoflurane anesthesia for five minutes. Muscle tissue
      oxygenation is measured bilaterally in the anterior tibial muscle by near-infrared
      spectroscopy (INVOS, SOMANETICS, Troy, Michigan/ USA) during preconditioning and following
      ischemia.Clinically relevant ischemia was defined as a decrease of tissue oxygen saturation
      to 95 % of baseline.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease of tissue oxygen saturation below 95 % of baseline</measure>
    <time_frame>4 hours</time_frame>
    <description>Decrease of tissue oxygen saturation below 95 % of baseline</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Tissue Oxygen Saturation</condition>
  <arm_group>
    <arm_group_label>Sevoflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sevoflurane Preconditioning</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Sevoflurane</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No Sevoflurane Preconditioning</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sevoflurane preconditioning</intervention_name>
    <description>Preconditioning by transient application of sevoflurane</description>
    <arm_group_label>Sevoflurane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:vascular surgery with clamping of a femoral artery. -

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Axel Fudickar, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Schleswig-Holstein, Campus Kiel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Schleswig-Holstein, Campus Kiel</name>
      <address>
        <city>Kiel</city>
        <state>Schleswig-Holstein</state>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 14, 2014</study_first_submitted>
  <study_first_submitted_qc>January 15, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2014</study_first_posted>
  <last_update_submitted>November 27, 2016</last_update_submitted>
  <last_update_submitted_qc>November 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Schleswig-Holstein</investigator_affiliation>
    <investigator_full_name>Axel Fudickar</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

